Living Donor Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Living Donor clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Not Applicable

The Effects of Transversalis Fascia Plane Block on Opioid Consumption in Patients Undergoing Hand-Assisted Laparoscopic Donor Nephrectomy: A Randomized Controlled Prospective Study

Pain ManagementPostoperative PainAnalgesics, Opioid+3 more
Koç University50 enrolled1 locationNCT07396753
Recruiting
Not Applicable

Rectus-Intercostal Fascial Plane Block for Liver Transplantation Donors

Postoperative PainLiver TransplantationLiving Donor
Istinye University64 enrolled1 locationNCT07233096
Recruiting

Longitudinal Follow-up and Health-Related Outcomes in Liver Transplant Recipients and Living Donors

Living Donor Liver Transplantation RecipientsDeceased Donor Liver Transplantation RecipientsLiving Liver Donor
Second Affiliated Hospital, School of Medicine, Zhejiang University9,999 enrolled1 locationNCT07301853
Recruiting

Multiparametric MRI in a Prospective Cohort of Living Kidney Donors, Recipients, and Healthy Controls: Correlations With Markers of Renal Function, Fibrosis and Ageing

Kidney TransplantationLiving DonorsMultiparametric Magnetic Resonance Imaging+1 more
Patrick Schjelderup96 enrolled2 locationsNCT06210555
Recruiting

Proteinuria and Renal Perfusion in Renal Transplant Recipients

End Stage Renal DiseasePre-kidney TransplantLiving Donor Kidney Transplantation+1 more
University of Erlangen-Nürnberg Medical School25 enrolled1 locationNCT06051812
Recruiting

A search of novel biomarkers in detecting early allograft dysfunction afterliving donor liver transplantation

early allograft dysfunctionliving donor liver transplantation
Chang Gung Memorial Hospital120 enrolled1 locationACTRN12619000386134